clarithromycin has been researched along with Pulmonary Edema in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lim, TK; Mukhopadhyay, A; Pandya, GJ; Ping, CA | 1 |
Bienias, P; Ciurzyński, M; Paczyńska, M; Pruszczyk, P | 1 |
Fukuno, Y; Hayashi, S; Kawashima, M; Nagata, M; Tominaga, M; yatsunami, J | 1 |
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
4 other study(ies) available for clarithromycin and Pulmonary Edema
Article | Year |
---|---|
Unilateral lobar pulmonary edema.
Topics: Aged; Anti-Bacterial Agents; Cardiomyopathy, Alcoholic; Ceftriaxone; Clarithromycin; Diagnosis, Differential; Diuretics; Echocardiography, Doppler; Furosemide; Heart Failure; Humans; Male; Pulmonary Edema; Treatment Outcome | 2012 |
Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clarithromycin; Drug Therapy, Combination; Electrocardiography; Heart Arrest; Humans; Long QT Syndrome; Male; Middle Aged; Pneumonia; Pulmonary Edema; Torsades de Pointes; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Apoptosis; Azithromycin; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Growth Substances; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Josamycin; Lung; Male; Mice; Mice, Inbred ICR; Pulmonary Edema; Respiratory Distress Syndrome; Roxithromycin; Time Factors; Treatment Outcome | 2002 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |